REAL‐WORLD OUTCOMES OF PATIENTS (PT) WITH RELAPSED OR REFRACTORY (R/R) CLL/SLL AND PRIOR TREATMENT (TX) WITH BOTH A BRUTON TYROSINE KINASE INHIBITOR (BTKI) AND VENETOCLAX.
| Published in: | Hematological Oncology Vol. 41; pp. 733 - 735 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Published: |
Wiley-Blackwell
Jun2023 Supplement S2
|
| Online Access: | View this record in EBSCOhost |